Overview

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Status:
Not yet recruiting

Trial end date:
2023-08-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the safety and effectiveness of OC-01 (varenicline solution) Nasal Spray as compared to placebo (vehicle) on signs and symptoms of dry eye disease.

Phase:

Phase 3

Details

Lead Sponsor:

Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.

Collaborator:

Oyster Point Pharma, Inc.

Treatments:

Varenicline